CORRESP Filing
CNS Pharmaceuticals, Inc.
Date: April 17, 2025 · CIK: 0001729427 · Accession: 0001683168-25-002657
AI Filing Summary & Sentiment
File numbers found in text: 333-286529
Show Raw Text
CORRESP 1 filename1.htm A.G.P. / Alliance Global Partners 590 Madison Ave., 28th Floor New York, NY 10022 April 17, 2025 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Re: CNS Pharmaceuticals, Inc. Registration Statement on Form S-1 File No. 333-286529 (the "Registration Statement") Ladies and Gentlemen: Reference is made to our letter, filed as correspondence via EDGAR on April 14, 2025, in which A.G.P/Alliance Global Partners as Placement Agent, joined the Company's request for acceleration of the effective date of the above-referenced Registration Statement for 5:00 p.m. Eastern Time on April 16, 2025, or as soon thereafter as practicable, in accordance with Rule 461 under the Securities Act of 1933, as amended. The Company is no longer requesting that such Registration Statement be declared effective at this time and we hereby formally withdraw our request for acceleration of the effective date. Very truly yours, A.G.P / Alliance Global Partners By: /s/ Thomas J. Higgins Name: Thomas J. Higgins Title: Managing Director